Tourette Syndrome Treatment for Adults
Adults with Tourette syndrome face unique challenges. Many have tried and discontinued medication due to cognitive side effects that interfere with professional and creative work. The existing treatment landscape — antipsychotics, alpha-2 agonists, CBIT — was largely designed for pediatric populations and does not adequately address the needs of adults who require full cognitive function for demanding careers.
InhibiTic was designed by an adult with Tourette syndrome who stopped medication because the cognitive side effects made it impossible to code, think creatively, and function in a high-performance environment. Every design decision — the 8-hour battery for a full workday, the discreet headband form factor, the cognitive dashboard for objective self-tracking — reflects the needs of adults who refuse to compromise their minds.
InhibiTic: On-demand tic suppression without cognitive dulling
Join the waitlist for early access to the first closed-loop neuroheadband for Tourette syndrome.
Join the Waitlist